Centogene NV (CNTGF)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Centogene NV (CNTGF) is up 14.3% since the beginning of the year. At $0 per share, CNTGF is trading 83.0% below its 52-week high of $1. Investors who bought $1,000 worth of CNTGF shares 5 years ago would now be looking at an investment worth $13.

Centogene NV (CNTGF) has returned 14.29% so far this year and -17.24% over the past 12 months.

Based on dividend-adjusted daily data since Nov 7, 2019, CNTGF's average daily return is +0.41%, while the average monthly return is -2.33%.

Historically, 43% of months were positive and 58% were negative. The best month was Sep 2024 with a return of +85.7%, while the worst month was Jul 2025 at -60.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CNTGF closed higher 41% of trading days. The best single day was Jul 29, 2025 with a return of +300.0%, while the worst single day was Jul 17, 2025 at -92.6%.

Centogene NV has an annualized alpha of 172.66%, beta of 0.18, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 08, 2019.

• This stock participated in 69.45% of S&P 500 Index downside but only -96.06% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.18 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CNTGF ranks 60 for risk / return — better than 60% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Centogene NV (CNTGF) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Centogene NV. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Centogene NV was 99.96%, occurring on Jul 18, 2025. The portfolio has not yet recovered.

The current Centogene NV drawdown is 99.52%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Centogene NV over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Centogene NV is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.